COVID-19 in the Hematology Hospital, Course and Outcomes
The new coronavirus infection COVID-19 complicates treatment and worsens the prognosis in patients with diseases of the blood system. After analyzing the experience of one hematological hospital, the impact of the new coronavirus infection COVID-19 on the course of diseases of the blood system and outcomes was assessed. In the period from February 2020 to March 2021, 1150 patients were treated in the hematology hospital; each patient received 3-4 courses of polychemotherapy. The total number of the infected with the new coronavirus infection was 186 patients (16.7%). The number of deaths from the total number of those receiving treatment was 24.7%. The results of clinical and hematological studies showed a predominantly unfavorable course of the new coronavirus infection COVID-19 in patients with diseases of the blood system, unfavorable outcome in all studied nosological groups of patients with COVID-19 who were on outpatient and inpatient treatment. It is necessary to investigate the immune status in depth to determine the relationship with the outcome of the disease.